President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials railed against the drug industry and painted the order as

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of prescriptions in America by volume, cost around a third less than in other rich countries, according to the rand Corporation, a think-tank.

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations to push industry talking points in Washington and across the nation.

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

In a significant move, President Trump announced his intention to sign an executive order aimed at reducing the cost of prescription medications. Join us as we discuss the details of this plan and its potential impact on patients and the healthcare industry.